Basepoint Wealth’s Amgen AMGN Stock Holding History

Basepoint Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.7K	Buy	273 +2	+0.7%	+$685	0.06%	158
2026 Q1	$95.2K	Buy	271 +3	+1%	+$1.07K	0.05%	149
2025 Q4	$88K	Buy	+268	New	+$85K	0.05%	153

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Basepoint Wealth's AMGN Position: Q2 2026 in Review

Basepoint Wealth increased its Amgen (AMGN) stake by 0.74% in Q2 2026, buying an estimated $685 and bringing the position to 273 shares worth $98.7K. The position accounts for 0.06% of the portfolio, ranked #158.

Basepoint Wealth first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Basepoint Wealth held 273 shares of Amgen worth $98.7K as of Q2 2026.
Basepoint Wealth bought 2 Amgen shares in Q2 2026, an estimated $685.
Amgen made up 0.06% of Basepoint Wealth's portfolio in Q2 2026, its #158 holding.
Basepoint Wealth first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Basepoint Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.